Search
forLearn
1 / 1 resultsResearch
5 / 27 results
research Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.
research Investigating the Mechanisms Underlying the Pathogenesis of Alopecia Areata
Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.
research Evaluation of SARS-CoV-2 Entry, Inflammation, and New Therapeutics in Human Lung Tissue Cells
A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.
research Experimental and Thermodynamic Analyses of Supercritical CO2 Solubility of Minoxidil as an Antihypertensive Drug
Minoxidil dissolves better in propylene glycol + water than in supercritical CO2.
research Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-Conditioning
Changing how mesenchymal stromal cells are grown can improve their healing abilities.
Community Join
2 / 2 resultscommunity BosleyMD Revive+ Serum… Has anyone tried this yet? Any reviews or opinions?
The conversation is about BosleyMD Revive+ Serum, which uses Y100 Compound instead of Minoxidil. The user is seeking reviews or opinions on this newer product.
community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025
Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.